Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Juli 2024

Biotek-snakken — Juli 2024

Planlagt Fastgjort Låst Flyttet Biotek-snakken
94 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • L Offline
    L Offline
    LP90
    wrote on sidst redigeret af
    #34

    Godmorgen 🙂

    1 Reply Last reply
    0
    • exitnuE Offline
      exitnuE Offline
      exitnu
      wrote on sidst redigeret af
      #35

      God morgen 🙂

      1 Reply Last reply
      0
      • exitnuE Offline
        exitnuE Offline
        exitnu
        wrote on sidst redigeret af
        #36

        ASCELIA PHARMA CARRIES OUT A RIGHTS ISSUE OF UNITS OF APPROXIMATELY SEK 105 MILLION TO FULLY FINANCE THE NDA SUBMISSION FOR ORVIGLANCE®

        Link Preview Image
        Ascelia Pharma Carries Out a Rights Issue of Units of Approximately SEK 105 Million to Fully Finance the NDA Submission for Orviglance® – ASCELIA

        NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, ...

        favicon

        (www.ascelia.com)

        1 Reply Last reply
        0
        • exitnuE Offline
          exitnuE Offline
          exitnu
          wrote on sidst redigeret af
          #37

          Ascelia: Proceeds with a SEK 105m rights issue of units

          Just a moment...

          favicon

          (www.redeye.se)

          1 Reply Last reply
          0
          • exitnuE Offline
            exitnuE Offline
            exitnu
            wrote on sidst redigeret af
            #38

            " ... We regard this initiative as positive. Ascelia will be in a strong position to negotiate terms with a US partner, and the funding will dramatically reduce the financial uncertainty in Ascelia. The proposed funding will also allow Ascelia to focus on securing FDA approval for Orviglance and securing a US commercial partner on favourable terms."

            1 Reply Last reply
            0
            • Z Offline
              Z Offline
              Zambo
              wrote on sidst redigeret af
              #39

              Ascelia Pharma: Trist udvikling på kursen siden fase 3 udmelding. Kunne det ikke være meldt mere klart ud hvad kursen på emission ville være

              1 Reply Last reply
              0
              • exitnuE Offline
                exitnuE Offline
                exitnu
                wrote on sidst redigeret af
                #40

                33.757.746 aktier x kurs ca. 6 = pt. børsværdi 202 MSEK 🙂

                Læs d.d. RESEARCH NOTE fra Redeye!

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #41

                  BioArctic : Eisai's Leqembi Approved In Israel For Alzheimer's Disease Treatment https://proinvestor.com/investornyt/1184229/bioarctic-eisais-leqembi-approved-in-israel-for-alzheimers-disease-treatment

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    ProinvestorNEWS
                    wrote on sidst redigeret af
                    #42

                    Immutep's Eftilagimod Alfa Combination Shows Positive Phase IIb Results In Head & Neck Cancer Trial https://proinvestor.com/investornyt/1184225/immuteps-eftilagimod-alfa-combination-shows-positive-phase-iib-results-in-head-amp-neck-cancer-trial

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #43

                      15 Healthcare Stocks Hit New Highs: Did You Spot These Winners? https://proinvestor.com/investornyt/1184904/15-healthcare-stocks-hit-new-highs-did-you-spot-these-winners

                      1 Reply Last reply
                      0
                      • F Offline
                        F Offline
                        Fandel
                        wrote on sidst redigeret af
                        #44

                        Godmorgen...

                        1 Reply Last reply
                        0
                        • L Offline
                          L Offline
                          LP90
                          wrote on sidst redigeret af
                          #45

                          Godmorgen 🙂

                          1 Reply Last reply
                          0
                          • J Offline
                            J Offline
                            Jazzz
                            wrote on sidst redigeret af
                            #46

                            https://storage.mfn.se/7a455d65-f919-4ef8-b60b-b1ff5bb5dfe0/acarix-receives-sizeable-patch-reorder-from-louisiana-primary-care-clinic.pdf

                            1 Reply Last reply
                            0
                            • J Offline
                              J Offline
                              Jazzz
                              wrote on sidst redigeret af
                              #47

                              Acarix

                              1 Reply Last reply
                              0
                              • J Offline
                                J Offline
                                Jazzz
                                wrote on sidst redigeret af
                                #48

                                Just a moment...

                                favicon

                                (www.acarix.com)

                                1 Reply Last reply
                                0
                                • J Offline
                                  J Offline
                                  Jazzz
                                  wrote on sidst redigeret af
                                  #49

                                  3.og sidste gode nyhed.. https://www.acarix.com/news/press/acarix-shares-begin-trading-on-the-us-based-otcqb-market

                                  1 Reply Last reply
                                  0
                                  • A Offline
                                    A Offline
                                    Aps_invest
                                    wrote on sidst redigeret af
                                    #50

                                    Og kunne Acarix så også lige få flere store ordrer, så bliver “lodsedlen” sjov, Jazz…
                                    spændende 🙂

                                    1 Reply Last reply
                                    0
                                    • A Offline
                                      A Offline
                                      Aps_invest
                                      wrote on sidst redigeret af
                                      #51

                                      Ihvertfald ikke nu man skal sælge, hvor tingene begynder for alvor at tage fart. Men heller ikke en aktie man skal smide for mange penge efter, før vi ser endnu flere gode nyheder der bekræfter gennembruddet.

                                      1 Reply Last reply
                                      0
                                      • F Offline
                                        F Offline
                                        Fandel
                                        wrote on sidst redigeret af
                                        #52

                                        Godmorgen...

                                        1 Reply Last reply
                                        0
                                        • L Offline
                                          L Offline
                                          LP90
                                          wrote on sidst redigeret af
                                          #53

                                          Godmorgen 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper